Congenica

About:

Congenica is a biotechnology company that provides a diagnostic decision support platform.

Twitter/X: congenica

Top Investors: Cambridge Innovation Capital, Future Planet Capital, Parkwalk Advisors, Tencent, BGI Group

Description:

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

Total Funding Amount:

$82.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2012-01-01

Contact Email:

info(AT)congenica.com

Founders:

Eugene Bragin, Matthew Hurles, Nick Lench, Philip Beales, Richard Durbin, Thomas Weaver

Number of Employees:

51-100

Last Funding Date:

2021-03-04

IPO Status:

Private

Industries: